These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7947367)

  • 1. Nitrates in congestive heart failure.
    Dupuis J
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):501-7. PubMed ID: 7947367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
    Elkayam U; Bitar F
    Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
    Thadani U
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):735-42. PubMed ID: 9110117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrates in the treatment of congestive heart failure.
    Elkayam U
    Am J Cardiol; 1996 May; 77(13):41C-51C. PubMed ID: 8638526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrates for congestive heart failure.
    Cohn JN
    Am J Cardiol; 1985 Jul; 56(2):19A-23A. PubMed ID: 4014049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nitrates in heart failure: the hemodynamic effects and clinical implications].
    Faggiano P; Rusconi C; Ghizzoni G
    Cardiology; 1994; 84 Suppl 1():52-63. PubMed ID: 8087825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure.
    Elkayam U; Roth A; Mehra A; Ostrzega E; Shotan A; Kulick D; Jamison M; Johnston JV; Rahimtoola SH
    Circulation; 1991 Nov; 84(5):2040-8. PubMed ID: 1934379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure.
    Bauer JA; Fung HL
    Circulation; 1991 Jul; 84(1):35-9. PubMed ID: 1905595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure.
    Franciosa JA; Cohn JN
    Am J Cardiol; 1979 May; 43(5):1009-14. PubMed ID: 433762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New perspectives on therapeutic application of nitrates as vasodilator agents for severe chronic heart failure.
    Packer M
    Am J Med; 1983 Jun; 74(6B):61-72. PubMed ID: 6859073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrate resistance and tolerance: potential limitations in the treatment of congestive heart failure.
    Elkayam U; Mehra A; Shotan A; Ostrzega E
    Am J Cardiol; 1992 Sep; 70(8):98B-104B. PubMed ID: 1529933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine in chronic CHF.
    Chatterjee K; Rouleau JL; Massie BM
    Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac failure and nitrates].
    Galinier M; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1997; 46(7):415-9. PubMed ID: 9452775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral nitrates: more than symptomatic therapy in coronary artery disease?
    Thadani U
    Cardiovasc Drugs Ther; 1997 May; 11 Suppl 1():213-8. PubMed ID: 9211013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action and efficacy of nitrates in heart failure.
    Cohn JN
    Am J Cardiol; 1992 Sep; 70(8):88B-92B. PubMed ID: 1529931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrates and nitrate tolerance in congestive heart failure.
    Abrams J
    Coron Artery Dis; 1993 Jan; 4(1):27-36. PubMed ID: 7903589
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of organic nitrates in the treatment of heart failure.
    Elkayam U; Karaalp IS; Wani OR; Tummala P; Akhter MW
    Prog Cardiovasc Dis; 1999; 41(4):255-64. PubMed ID: 10362348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic factors limiting the response to transdermal nitroglycerin in severe chronic congestive heart failure.
    Packer M; Medina N; Yushak M; Lee WH
    Am J Cardiol; 1986 Feb; 57(4):260-7. PubMed ID: 3080861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.